Filtered By:
Vaccination: Shingles (Herpes Zoster) Vaccine
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 214 results found since Jan 2013.
One Dose Of Coronavirus Vaccine Likely Won ’ t Be Enough; ‘ We ’ re Looking At Double Shots ’
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p1").init({"mcp":"cbs","width":"100%","height":"100%","video":"4683970","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p1","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId":"sc_va","marketingCloudId":"823BA0335567497F7F000101@AdobeOrg","trackingServer":"cbsdigitalmedia.hb.omtrdc.net","customTrackingServer":"cbsdigitalmedia.d1.sc.omtrdc.net","chapterTracking":false,"version":"1.5"},"comscore":{"clientId"...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - August 31, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated CBSN Boston CNN Coronavirus Coronavirus Vaccine Source Type: news
Herpetic anterior uveitis following Pfizer –BioNTech coronavirus disease 2019 vaccine: two case reports
ConclusionClinicians should be aware of the possibility of eye inflammation in the form of herpetic reactivation after coronavirus disease 2019 vaccination.
Source: Journal of Medical Case Reports - March 25, 2022 Category: General Medicine Source Type: research
Herpetic anterior uveitis following Pfizer-BioNTech coronavirus disease 2019 vaccine: two case reports
CONCLUSION: Clinicians should be aware of the possibility of eye inflammation in the form of herpetic reactivation after coronavirus disease 2019 vaccination.PMID:35337364 | DOI:10.1186/s13256-022-03350-6
Source: Herpes - March 26, 2022 Category: Infectious Diseases Authors: Jos é Manuel Ortiz-Egea Cristina G ómez Sánchez Andr és López-Jiménez Olga Diego Navarro Source Type: research
Moderna Says Its COVID-19 Vaccine Is 94.5% Effective In Early Tests
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p12").init({"mcp":"cbs","width":"100%","height":"100%","video":"4873156","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p12","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId":"sc_va","marketingCloudId":"823BA0335567497F7F000101@AdobeOrg","trackingServer":"cbsdigitalmedia.hb.omtrdc.net","customTrackingServer":"cbsdigitalmedia.d1.sc.omtrdc.net","chapterTracking":false,"version":"1.5"},"comscore":{"clientI...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 16, 2020 Category: Consumer Health News Authors: CBS Boston Tags: Boston News Covid-19 Boston, MA Featured Healthcare Status Syndicated CBSN Boston Coronavirus Coronavirus Vaccine Moderna Moderna Therapeutics Source Type: news
Herpes zoster following vaccination with ChAdOx1 nCoV-19 Coronavirus vaccine (recombinant)
We report a case series of 7 patients who developed herpes zoster (HZ) following the first dose of ChAdOx1 nCoV-19 coronavirus vaccine (recombinant). HZ following vaccination is a rare entity. The occurrence of HZ in the patients presented in this series within the time window 1–21 days after vaccination defined for increased risk and postulated dysregulation of T-cell-mediated immunity, suggests that the ChAdOx1 nCoV-19 coronavirus vaccine (recombinant) could probably be a trigger for reactivation of varicella zoster virus to cause HZ in them.
Source: Indian Journal of Public Health - April 5, 2022 Category: International Medicine & Public Health Authors: Anupa Mary Job Bindurani Sudhamani Manju Mohan SN Mohanasundaram Source Type: research
Varicella-Zoster virus reactivation following severe acute respiratory syndrome coronavirus 2 vaccination or infection: New insights
CONCLUSION: This study indicates that the occurrence of VZV reactivation is clinically relevant. However, our findings suggest that COVID-19 vaccination is safe, and remains strongly recommended.PMID:35931613 | DOI:10.1016/j.ejim.2022.07.022
Source: Herpes - August 5, 2022 Category: Infectious Diseases Authors: Raquel Martinez-Reviejo Sofia Tejada Ganiyat A R Adebanjo Camilla Chello Miriam C Machado Francesca R Parisella Magda Campins Antonella Tammaro Jordi Rello Source Type: research
Health Officials Track Safety as COVID-19 Vaccines Roll Out
By LAURAN NEERGAARD AP Medical Writer
As COVID-19 vaccinations roll out to more and more people, health authorities are keeping close watch for any unexpected side effects.
On Tuesday, a health worker in Alaska suffered a severe allergic reaction after receiving the Pfizer COVID-19 vaccine. She is in the hospital for another night under observation while another worker, vaccinated Wednesday, has recovered. Doctors already knew to be on the lookout after Britain reported two similar cases last week.
Related: Emergency Considerations in COVID-19 Vaccine Administration
In the U.S., vaccine recipients are supposed ...
Source: JEMS Patient Care - December 17, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Source Type: news
